Related Experiment Video
Updated: Sep 17, 2025

08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
10.6K
Clinical Impact of Using an Exoscope in En Bloc Subtotal Temporal Bone Resection for Advanced Ear Cancer
Hidehito Kimura1, Ken-Ichi Nibu2, Tatsuya Furukawa2
1Department of Neurosurgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Head & Neck
|July 3, 2025
Summary
The ORBEYE exoscope improved surgical safety in en bloc subtotal temporal bone resection (STBR) for advanced ear cancer by reducing blood loss and preventing venous sinus injury.
Area of Science:
- Neurosurgery
- Otolaryngology
- Surgical Oncology
Background:
- Advanced ear cancer requires complex surgical resection, such as en bloc subtotal temporal bone resection (STBR).
- Minimizing intraoperative complications like blood loss and venous sinus injury is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the clinical impact of using the 4K three-dimensional ORBEYE exoscope compared to the conventional surgical microscope in en bloc STBR.
- To assess differences in operation time, blood loss, and venous sinus injury between the two surgical approaches.
Main Methods:
- Retrospective analysis of 21 patients undergoing en bloc ST-BR for lateral skull base malignancies.
- Comparison between patients operated with a conventional surgical microscope (SM) and those using the ORBEYE exoscope (OB).
- Key outcome measures included total operation time, neurosurgical duration, blood loss, and intraoperative venous sinus injury.
Main Results:
- The ORBEYE group showed significantly less blood loss compared to the SM group (p < 0.05).
- No venous sinus injuries occurred in the ORBEYE group, versus 15 in the SM group (p < 0.0001).
- Total operation time and the neurosurgical component duration were not significantly different between groups.
Conclusions:
- The use of the ORBEYE exoscope in en bloc STBR enhances surgical safety.
- ORBEYE facilitates reduced blood loss and eliminates venous sinus injury during advanced ear cancer resection.

